We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Facebook Launches AI Enhancement for MRI Scanners

By MedImaging International staff writers
Posted on 02 Sep 2020
Print article
Image: AI can help speed up and improve MRI scan quality (Photo courtesy of NYU Langone)
Image: AI can help speed up and improve MRI scan quality (Photo courtesy of NYU Langone)
Facebook (Menlo Park, CA, USA) and NYU Langone Medical Center (New York, NY, USA) have created an artificial intelligence (AI) system that can speed up magnetic resonance imaging (MRI) examinations.

The new system, called fastMRI, is based on a deep learning (DL) image reconstruction model optimized via dedicated multi-sequence training, in which a single reconstruction model is trained with data from multiple sequences with different contrast and orientations. Following training, data from 108 patients were retrospectively undersampled in a manner that would correspond with a net 3.49-fold acceleration of fully-sampled data acquisition and 1.88-fold acceleration. The ability of six readers to detect internal derangement of the knee was then compared for both clinical and DL-accelerated images.

The results demonstrated a high degree of interchangeability between the standard and DL-accelerated images; in particular, results showed that interchanging the sequences would result in discordant clinical opinions no more than 4% of the time for any feature evaluated. Moreover, the accelerated sequence was judged by all six readers to have better quality than the clinical sequence. The new technology also allowed creation of MRI films in 75% less time (about 15 minutes). The study was published on August 8, 2020, in the American Journal of Roentgenology.

“This study is an important step toward clinical acceptance and utilization of AI-accelerated MRI scans, because it demonstrates for the first time that AI-generated images are indistinguishable in appearance from standard clinical MR exams and are interchangeable in regards to diagnostic accuracy,” said lead author Professor Michael Recht, MD, of NYU Langone. “The results represent the culmination of nearly two years of open research from Facebook AI and NYU Langone’s fastMRI initiative, a collaborative effort to improve medical imaging technology and advance research using AI to generate images from limited data.”

Deep learning is part of a broader family of AI machine learning methods based on learning data representations, as opposed to task specific algorithms. It involves CNN algorithms that use a cascade of many layers of nonlinear processing units for feature extraction, conversion, and transformation, with each successive layer using the output from the previous layer as input to the new one in order to form a hierarchical representation.


Related Links:
Facebook
NYU Langone Medical Center


New
Cylindrical Water Scanning System
SunSCAN 3D
X-ray Diagnostic System
FDX Visionary-A
Multi-Use Ultrasound Table
Clinton
New
Biopsy Software
Affirm® Contrast

Print article

Channels

Radiography

view channel
Image: AI can identify “mammographically-visible” types of interval cancers earlier by flagging them at the time of screening (Photo courtesy of ScreenPoint Medical)

AI Improves Early Detection of Interval Breast Cancers

Interval breast cancers, which occur between routine screenings, are easier to treat when detected earlier. Early detection can reduce the need for aggressive treatments and improve the chances of better outcomes.... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.